Harnessing the power of synthetic biology to combat COVID-19
Learn how Dr. Dan Gibson and team approached completing the world’s first on-demand synthesis of the SARS-CoV-2 genome — the causal agent of COVID-19 — using a commercially available, automated DNA assembly and cloning instrument — the BioXp™ system.
The webinar from April 30, 2020, explores the hierarchical assembly of the full-length synthetic SARS-CoV-2 genome and its potential applications.
By clicking submit, you agree that Telesis Bio may use this information to contact you about our programs, products, or services. You may opt out at any time.